Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > guys, is dg in a book, if you go to the website

<< Previous

Bullboard Posts

Next >>

Comment by Nighttradeon Jul 14, 2020 1:04am

117 Views

Post# 31263797

RE:guys, is dg in a book, if you go to the website

The back of the book says 30 innovations. I assume he is one of the 30. I hope he didn't relay the PP for this BS. I hope he has an ace up his sleeve and this is part of the marketing strategy to bring profits to him and SHAREHOLDERS.

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter